The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia

The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia

Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Rivaldo Steven Heriyanto, Andree Kurniawan, Felix Wijovi, Devina Adella Halim, Claudia Jodhinata, Elizabeth Marcella, Billy Susanto, Johan Wibowo, Michele Indrawan, Nadia Khoirunnisa Heryadi, Michelle Imanuelly, Jonathan Juniard Anurantha, Timotius Ivan Hariyanto, Chintya Marcellin, Terry Devita Sinaga, Saraswati Anindita Rizki, Novia Sieto, Jeremia Immanuel Siregar, Nata Pratama Hardjo Lugito
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
COVID-19
antibody titers
Sinovac vaccine
COVID-19 vaccine
Infectious and parasitic diseases
RC109-216
Online Access:https://doaj.org/article/2d956e8e294e4a3280b6e0917a7395ac
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items